MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced ...

A global Phase III study in venous leg ulcers (VLUs) is currently underway, with a clinical study in diabetic foot ulcers ... for the enzymatic removal of eschar in thermal burns and is marketed ...

Currently, a global Phase III study in VLUs is underway, with a diabetic foot ulcers (DFUs) study in preparation. MediWound’s existing FDA-approved product, NexoBrid, is marketed for eschar ...

May 14, 2025 — A new study shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life do not ...

A diabetes eye exam or screening may include imaging tests, a dilated eye exam, and looking at letter charts on a wall to check for diabetes-related eye complications. A diabetes eye exam involves ...

Steve Christo – Corbis/Getty Images Semaglutide is a GLP-1 agonist medication that can assist with diabetes management and weight loss. Experts are interested in understanding additional ...

The brands Rybelsus and Ozempic are currently FDA-approved for diabetes management, and Wegovy is used to assist with weight loss. Experts are also interested in other uses of semaglutide.

When I told him that I was constantly thirsty and had to use the bathroom more times a day than was humanly acceptable, he ran some tests and found that I had developed type 2 diabetes.

Diabetes in pregnancy is associated with an increased risk of autism and attention deficit hyperactivity disorder (ADHD), a large meta-analysis has suggested. A Chinese study published in The Lancet ...

A type 2 diabetes symptom could show up at night, health experts warn. Diabetes UK states that more than 12 million people in the UK, or one in five adults, have either diabetes or prediabetes.